Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV-2 in Mice
Abigail E. Powell, Kaiming Zhang, Mrinmoy Sanyal, et al.
ACS Central Science (2021) Vol. 7, Iss. 1, pp. 183-199
Open Access | Times Cited: 169

Showing 1-25 of 169 citing articles:

Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome
Katharina Röltgen, Abigail E. Powell, Oliver F. Wirz, et al.
Science Immunology (2020) Vol. 5, Iss. 54
Open Access | Times Cited: 469
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development
Yingzhu Li, Rumiana Tenchov, Jeffrey Smoot, et al.
ACS Central Science (2021) Vol. 7, Iss. 4, pp. 512-533
Open Access | Times Cited: 316
Designing spatial and temporal control of vaccine responses
Gillie A. Roth, Vittoria C. T. M. Picece, Ben S. Ou, et al.
Nature Reviews Materials (2021) Vol. 7, Iss. 3, pp. 174-195
Open Access | Times Cited: 217
SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Daniel Martínez-Flores, Jesús Zepeda–Cervantes, Adolfo Cruz-Reséndiz, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 211
Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models
Alexander A. Cohen, Neeltje van Doremalen, Allison J. Greaney, et al.
Science (2022) Vol. 377, Iss. 6606
Open Access | Times Cited: 188
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
Philip J. M. Brouwer, Mitch Brinkkemper, Pauline Maisonnasse, et al.
Cell (2021) Vol. 184, Iss. 5, pp. 1188-1200.e19
Open Access | Times Cited: 181
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
Michael Joyce, Wei‐Hung Chen, Rajeshwer S. Sankhala, et al.
Cell Reports (2021) Vol. 37, Iss. 12, pp. 110143-110143
Open Access | Times Cited: 149
COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations
Qian He, Qunying Mao, Jialu Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 111
A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates
Michael Joyce, Hannah A. D. King, Inès Lakhal-Naouar, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 632
Open Access | Times Cited: 106
Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal models
Han-Yi Huang, Hsin-Yu Liao, Xiaorui Chen, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 639
Open Access | Times Cited: 99
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
Payton A. Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 56
ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines
Magnus A. G. Hoffmann, Zhi Yang, Kathryn E. Huey‐Tubman, et al.
Cell (2023) Vol. 186, Iss. 11, pp. 2380-2391.e9
Open Access | Times Cited: 42
Bringing immunofocusing into focus
Sriharshita Musunuri, Payton A. Weidenbacher, Peter S. Kim
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 21
Vaccine design via antigen reorientation
Duo Xu, Joshua Carter, Chunfeng Li, et al.
Nature Chemical Biology (2024) Vol. 20, Iss. 8, pp. 1012-1021
Open Access | Times Cited: 15
SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?
Saborni Chakraborty, Vamsee Mallajosyula, Cristina M. Tato, et al.
Advanced Drug Delivery Reviews (2021) Vol. 172, pp. 314-338
Open Access | Times Cited: 87
Functionalizing Ferritin Nanoparticles for Vaccine Development
Margarida Q. Rodrigues, Paula M. Alves, António Roldão
Pharmaceutics (2021) Vol. 13, Iss. 10, pp. 1621-1621
Open Access | Times Cited: 77
SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses
Joshua M. Carmen, Shikha Shrivastava, Zhongyan Lu, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 66
The self-assembled nanoparticle-based trimeric RBD mRNA vaccine elicits robust and durable protective immunity against SARS-CoV-2 in mice
Wenqiang Sun, Lihong He, He Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 65
An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19
Saman Yasamineh, Hesam Ghafouri Kalajahi, Pooneh Yasamineh, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 60
Challenges and developments in universal vaccine design against SARS-CoV-2 variants
Fangxin Zhao, Xiaodong Zai, Zhiling Zhang, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 56
Ferritin – a multifaceted protein scaffold for biotherapeutics
Na Kyeong Lee, Seongeon Cho, In‐San Kim
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 10, pp. 1652-1657
Open Access | Times Cited: 52
Ferritin self-assembly, structure, function, and biotechnological applications
Vsevolod V. Sudarev, Sofya M. Dolotova, Siarhei Bukhalovich, et al.
International Journal of Biological Macromolecules (2022) Vol. 224, pp. 319-343
Closed Access | Times Cited: 48
Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic
Ziqi Wang, Kai Cui, Ulrich Costabel, et al.
Exploration (2022) Vol. 2, Iss. 5
Open Access | Times Cited: 43
Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants
Yinfeng Kang, Cong Sun, Jing Sun, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 40
A novel view of ferritin in cancer
Bhavyata Shesh, James R. Connor
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 4, pp. 188917-188917
Closed Access | Times Cited: 31
Page 1 - Next Page

Scroll to top